{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T05:59:36Z","timestamp":1780984776387,"version":"3.54.1"},"reference-count":20,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2026,4,9]],"date-time":"2026-04-09T00:00:00Z","timestamp":1775692800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,4,9]],"date-time":"2026-04-09T00:00:00Z","timestamp":1775692800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["no.8l771738"],"award-info":[{"award-number":["no.8l771738"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Rheumatol"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1007\/s10067-026-07973-8","type":"journal-article","created":{"date-parts":[[2026,4,9]],"date-time":"2026-04-09T02:25:25Z","timestamp":1775701525000},"page":"3555-3563","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Evaluating the value of superoxide dismutase in anti-synthetase syndrome associated with interstitial lung disease"],"prefix":"10.1007","volume":"45","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4208-0964","authenticated-orcid":false,"given":"Lei","family":"Luo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenhan","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feifeng","family":"Ren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhihuan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Ke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0000-5487-4529","authenticated-orcid":false,"given":"Lin","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,9]]},"reference":[{"key":"7973_CR1","doi-asserted-by":"publisher","unstructured":"Tillie-Leblond I, Wislez M, Valeyre D et al (2009)Interstitial lung disease and anti-Jo-1antibodies: difference between acute and gradual onset. Thorax 63(1): 53e9.\u00a0https:\/\/doi.org\/10.1136\/thx.2006.069237.","DOI":"10.1136\/thx.2006.069237"},{"issue":"1","key":"7973_CR2","doi-asserted-by":"publisher","DOI":"10.1186\/s12890-016-0325-y","volume":"16","author":"H Sasano","year":"2016","unstructured":"Sasano H, Hagiwara E, Kitamura H et al (2016) Long-term clinical course of anti-glycyl tRNA synthetase (anti-EJ) antibody-related interstitial lung disease pathologically proven by surgical lung biopsy. BMC Pulm Med 16(1):168. https:\/\/doi.org\/10.1186\/s12890-016-0325-y","journal-title":"BMC Pulm Med"},{"issue":"5","key":"7973_CR3","doi-asserted-by":"publisher","first-page":"509","DOI":"10.3899\/jrheum.180778","volume":"46","author":"R Nakashima","year":"2019","unstructured":"Nakashima R, Yasui H, Suzuki Y et al (2019) Efficacy of glucocorticoids and cal cineurin inhibitors for anti-aminoacyl-tRNA synthetase antibody positive polymyositis\/dermatomyositis-associated interstitial lung disease: a propensity score-matched analysis. J Rheumatol 46(5):509\u2013517. https:\/\/doi.org\/10.3899\/jrheum.180778","journal-title":"J Rheumatol"},{"issue":"2","key":"7973_CR4","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1016\/j.resinv.2019.10.004","volume":"58","author":"R Takei","year":"2020","unstructured":"Takei R, Yamano Y, Kataoka K et al (2020) Predictive factors for the recurrence of anti-aminoacyl-tRNA synthetase antibody associated interstitial lung disease. Respir Investig 58(2):83\u201390. https:\/\/doi.org\/10.1016\/j.resinv.2019.10.004","journal-title":"Respir Investig"},{"issue":"3","key":"7973_CR5","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1007\/s00441-016-2445-3","volume":"365","author":"K Richter","year":"2016","unstructured":"Richter K, Kietzmann T (2016) Reactive oxygen species and fibrosis: furtherevidence of a significant liaison. Cell Tissue Res 365(3):591\u2013605. https:\/\/doi.org\/10.1007\/s00441-016-2445-3","journal-title":"Cell Tissue Res"},{"issue":"8","key":"7973_CR6","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2021.102869","volume":"20","author":"M Scherlinger","year":"2021","unstructured":"Scherlinger M, Tsokos GC (2021) Reactive oxygen species: the yin and yangin (auto-)immunity. Autoimmun Rev 20(8):102869. https:\/\/doi.org\/10.1016\/j.autrev.2021.102869","journal-title":"Autoimmun Rev"},{"key":"7973_CR7","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2020.101508","volume":"32","author":"Z Yan","year":"2020","unstructured":"Yan Z, Spaulding HR (2020) Extracellular superoxide dismutase, a molecular transducer of health benefits ofexercise. Redox Biol 32:101508. https:\/\/doi.org\/10.1016\/j.redox.2020.101508","journal-title":"Redox Biol"},{"key":"7973_CR8","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/rheumatology\/keac429","volume":"00","author":"W Huang","year":"2022","unstructured":"Huang W, Chen D, Wang Z et al (2022) Evaluating the value of superoxide dismutase in anti MDA5-positive dermatomyositis associated with interstitial lung disease. Rheumatology 00:1\u20137. https:\/\/doi.org\/10.1093\/rheumatology\/keac429","journal-title":"Rheumatology"},{"issue":"6","key":"7973_CR9","doi-asserted-by":"publisher","first-page":"1464","DOI":"10.1378\/chest.10-0180","volume":"138","author":"GR Connors","year":"2010","unstructured":"Connors GR, Christopher-Stine L, Oddis CV et al (2010) Interstitial lung disease associated with the idiopathic inflammatory myopathies: what progress has been made in the past 35 years? Chest 138(6):1464\u20131474. https:\/\/doi.org\/10.1378\/chest.10-0180","journal-title":"Chest"},{"issue":"2","key":"7973_CR10","doi-asserted-by":"publisher","first-page":"277","DOI":"10.1164\/ajrccm.165.2.ats01","volume":"165","author":"American Thoracic Society, European Respiratory Society","year":"2022","unstructured":"American Thoracic Society, European Respiratory Society (2022) American Thoracic Society\/European Respiratory Society international multidisciplinary consensus classification of the idiopathic interstitial pneumonias[J]. Am J Respir Crit Care Med 165(2):277\u2013304. https:\/\/doi.org\/10.1164\/ajrccm.165.2.ats01","journal-title":"Am J Respir Crit Care Med"},{"issue":"6","key":"7973_CR11","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1164\/rccm.201308-1483ST","volume":"188","author":"WD Travis","year":"2013","unstructured":"Travis WD, Costabel U, Hansell DM et al (2013) An Official American Thoracic Society\/European Respiratory Society statement: update of the International Multidisciplinary Classification of the Idiopathic Interstitial Pneumonias. Am J Respir Crit Care Med 188(6):733\u2013748. https:\/\/doi.org\/10.1164\/rccm.201308-1483ST","journal-title":"Am J Respir Crit Care Med"},{"issue":"10","key":"7973_CR12","doi-asserted-by":"publisher","first-page":"5349","DOI":"10.1007\/s00330-019-06152-5","volume":"29","author":"H Liu","year":"2019","unstructured":"Liu H, Xie S, Liang T et al (2019) Prognostic factors of interstitial lung disease progression at sequential HRCT in anti-synthetase syndrome. Eur Radiol 29(10):5349\u20135357. https:\/\/doi.org\/10.1007\/s00330-019-06152-5","journal-title":"Eur Radiol"},{"issue":"12","key":"7973_CR13","doi-asserted-by":"publisher","first-page":"1734","DOI":"10.1111\/1756-185X.14023","volume":"23","author":"Y Xu","year":"2020","unstructured":"Xu Y, Zhou J, Dong X et al (2020) Risk factors for progression and prognosis of primary Sj\u00f6gren\u2019s syndrome\u2010associated interstitial lung disease in a Chinese population. Int J Rheum Dis 23(12):1734\u20131740. https:\/\/doi.org\/10.1111\/1756-185X.14023","journal-title":"Int J Rheum Dis"},{"issue":"3","key":"7973_CR14","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1177\/2397198320902667","volume":"5","author":"K Huang","year":"2020","unstructured":"Huang K, Aggarwal R (2020) Antisynthetase syndrome: a distinct disease spectrum. J Scleroderma Relat Disord 5(3):178\u2013191. https:\/\/doi.org\/10.1177\/2397198320902667","journal-title":"J Scleroderma Relat Disord"},{"key":"7973_CR15","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1016\/j.autrev.2012.01.006","volume":"11","author":"I Maie","year":"2012","unstructured":"Maie I, Josse S, Decaux O et al (2012) Comparison of long-term outcome between anti-Jo-1 and anti-PL7\/PL12 positive patients with antisynthetase syndrome. Autoimmun Rev 11:739\u2013745. https:\/\/doi.org\/10.1016\/j.autrev.2012.01.006","journal-title":"Autoimmun Rev"},{"issue":"1","key":"7973_CR16","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1007\/s00109-019-01845-2","volume":"98","author":"NH Nguyen","year":"2020","unstructured":"Nguyen NH, Tran GB, Nguyen CT (2020) Anti-oxidative effects of superoxide dismutase 3 on inflammatory diseases. J Mol Med (Berl) 98(1):59\u201369. https:\/\/doi.org\/10.1007\/s00109-019-01845-2","journal-title":"J Mol Med (Berl)"},{"key":"7973_CR17","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.729602","volume":"12","author":"S Sun","year":"2021","unstructured":"Sun S, Chen Z, Zhang D et al (2021) Description and analysis of a novel subtype of the anti-synthetase syndrome characterized by frequent attacks of fever and systemic inflammation in a single center cohort study. Front Immunol 12:729602. https:\/\/doi.org\/10.3389\/fimmu.2021.729602","journal-title":"Front Immunol"},{"issue":"2","key":"7973_CR18","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1016\/j.autrev.2012.06.006","volume":"12","author":"B Hervier","year":"2012","unstructured":"Hervier B, Devilliers H, Stanciu R et al (2012) Hierarchical cluster and survival analyses of antisynthetase syndrome: phenotype and outcome are correlated with anti-tRNA synthetase antibody specificity. Autoimmun Rev 12(2):210\u2013217. https:\/\/doi.org\/10.1016\/j.autrev.2012.06.006","journal-title":"Autoimmun Rev"},{"key":"7973_CR19","doi-asserted-by":"publisher","first-page":"219","DOI":"10.1183\/09031936.06.00053805","volume":"28","author":"I Rahman","year":"2016","unstructured":"Rahman I, Adcock IM (2016) Oxidative stress and redox regulation of lung inflammation in COPD. Eur Respir J 28:219\u2013242. https:\/\/doi.org\/10.1183\/09031936.06.00053805","journal-title":"Eur Respir J"},{"issue":"10","key":"7973_CR20","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1002\/cphy.c190017","volume":"2020","author":"E Otoupalova","year":"2020","unstructured":"Otoupalova E, Smith S, Cheng G et al (2020) Oxidative stress in pulmonary fibrosis. Compr Physiol 2020(10):509\u2013547. https:\/\/doi.org\/10.1002\/cphy.c190017","journal-title":"Compr Physiol"}],"container-title":["Clinical Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-026-07973-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s10067-026-07973-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s10067-026-07973-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T05:25:22Z","timestamp":1780982722000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s10067-026-07973-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,9]]},"references-count":20,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["7973"],"URL":"https:\/\/doi.org\/10.1007\/s10067-026-07973-8","relation":{},"ISSN":["0770-3198","1434-9949"],"issn-type":[{"value":"0770-3198","type":"print"},{"value":"1434-9949","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,9]]},"assertion":[{"value":"24 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 December 2025","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 January 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"9 April 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"There is no conflict of interest regarding this manuscript, and this manuscript has the approval from all authors for publication.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}